Navigation Links
Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Date:1/7/2014

HOUSTON, Jan. 7, 2014 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. announced today that it has completed a second and final closing of its Series B financing, securing an additional $14.7 million and bringing the total raised in the round to $34.4 million. Current investors provided the additional funding, including AVG Ventures and Remeditex Ventures.

The funding will be used to expand clinical development of Bellicum's lead cellular immunotherapy product candidates.

"Bellicum is well positioned within the highly promising field of cellular immunotherapy with a technology that provides control over cells after they have been administered to the patient," said Bellicum CEO Tom Farrell. "This funding will be used to advance our two clinical programs in leukemia/lymphoma and prostate cancer, and launch studies in additional indications where there is urgent need for safer and more effective cell therapies."

Bellicum's two lead clinical development programs utilize the Company's unique ability to control cell therapies once inside the body. BPX-501 T cells contain the Company's CaspaCIDe™ gene "safety switch," enabling physicians to eliminate transplanted cells in the event they become harmful to the patient. The product is being evaluated in a Phase I/II study to reduce or eliminate Graft versus Host Disease in cancer patients undergoing hematopoietic stem cell transplant.

BPX-201 dendritic cells contain the Company's DeCIDe® gene "on switch," which enables physicians to strategically target immune activation for a more potent anti-tumor effect. It is being evaluated in a Phase I clinical trial in patients with metastatic castrate-resistant prostate cancer.

About Bellicum Pharmaceuticals

Bellicum is dedicated to developing safer and more effective cell therapies to treat cancers and other serious, life-threatening diseases. The Company's cel
'/>"/>

SOURCE Bellicum Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 13
2. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
3. ANI Pharmaceuticals Enters Development Agreement for Generic Drug Product with Sterling Pharmaceutical Services
4. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
5. Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
6. Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
7. Global Radiopharmaceuticals Market Report 2013 - 2018
8. Pre-Market Update: MGT Capital Investments, National American University Holdings and Actinium Pharmaceuticals
9. ANI Pharmaceuticals Acquires 31 Generic Drug Products from Teva Pharmaceuticals
10. New Appointments, and Share Price Movements - Research Report on Humana, Illumina, Edwards Lifesciences, Aegerion Pharmaceuticals, and CytRx
11. Taiwan Spends a High Percentage of its Healthcare Budget on Pharmaceuticals, but Second Generation Healthcare Reform is Transforming the Market Landscape
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... YORK , May 27, 2015  Precision Advisors ... the findings from its 2015 Digital Trends Study of ... makers are aware of the concepts of big data ... implement them.  The Health Information Technology ... for healthcare providers to make use of electronic medical ...
(Date:5/27/2015)... SEATTLE , May 27, 2015  LumiThera ... a non-invasive photobiomodulation (PBM) treatment for ocular disorders ... a Washington State Life ... of 3 recipients of the LSDF matching grants ... a treatment for subjects with dry age-related macular ...
(Date:5/27/2015)... , May 26, 2015 Research and ... "Asia Pacific Mammography Market - Growth, Trends And ... offering. Mammography is a detailed type of ... breasts. A mammography exam, called a mammogram, is used ... breast diseases in women. An x-ray (radiograph) is a ...
Breaking Medicine Technology:Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2Asia Pacific Mammography Market Trends and Forecasts 2015-2019 2
... Calif., June 9 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... 2a proof-of-concept clinical trial with AZ-002 (Staccato(R),alprazolam) in ... meet its two,primary endpoints, which were the effect ... attack and the effect of AZ-002 on the ...
... University of Rochester Medical Center study reports this juice has ... beneficial effects on older adults with insomnia, NEW ... juice blend based on the proven health benefits of,cherries -- ... a,study by the University of Rochester Medical Center. This double-blind,placebo ...
Cached Medicine Technology:Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 2Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 3Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder 4CherryPharm First All-Natural Food to Improve Sleep 2
(Date:5/27/2015)... Florida (PRWEB) May 27, 2015 ... impartial customer satisfaction surveys in the multiple services ... poll to determine the highest ranked Electronic Health ... part of a special research focus on implemented ... announced those software vendors with the highest scores ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CURE® ... (BCAN) , whose mission is to advance research, provide ... have joined forces to battle the fifth most common ... the bladder’s lining start to grow out of control. ... their families at every stage of the cancer experience ...
(Date:5/27/2015)... The MedSpa at Hendrick is excited ... treatments in Abilene, Texas: Xeomin®, Belotero Balance® and Radiesse®. ... glabellar lines, better known as the lines between the ... to treat smoker’s lines around the mouth and marionette ... improves the appearance of smile lines or lines around ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
(Date:5/27/2015)... May 27, 2015 Coco Libre announced today ... able to reach for Organic Coconut Water to quench their ... be available at VIP areas, artist greenrooms, corporate skyboxes and ... at area hotels and on festival shuttle buses. , ... year,” said Noa Elan, Director of Strategic Partnerships for Latitude ...
Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2
... Intensive insulin therapy significantly increases the risk of hypoglycemia ... CMAJ ( http://www.cmaj.ca/press/cmaj.090206.pdf ). , Intensive insulin therapy ... world as a means to tightly regulate blood sugar. ... standard of care for critically ill patients by many ...
... help representatives provide when SSDI benefits hit roadblocks , ... ... disability benefits, people can run into hurdles before those funds start ... of people in the Social Security Disability Insurance (SSDI) ...
... Thailand,s "Best Small Cap Company" in the December 2008/January 2009 issue ... award is the result of Asiamoney,s annual poll of fund managers ... corporations across the region. , ... Bangkok, Thailand (PRWEB) ...
... Greene supports 10-year-old Cassidy Megan,s Purple Day USA by turning DrGreene.com purple ... ... March 18, 2009-- Pediatrician and author Dr. Alan Greene is known for ... be adding a splash of purple., , , , ,March 26 is ...
... Meningitis Angels, a Texas-based, national nonprofit ... to support the first annual World Meningitis ... observance is being coordinated and promoted by ... Australia-based global advocacy group comprised of advocacy ...
... YORK, March 23 Did you know one in ... their lifetime?Listen to this report from Men,s Health Network ... Institute estimates over 186,000 men will be diagnosed with ... It,s important to realize that prostate cancer does ...
Cached Medicine News:Health News:NICE SUGAR: Intensive insulin therapy risks 2Health News:Getting Social Security Disability Benefits Isn't Simple, Even After Approval 2Health News:Getting Social Security Disability Benefits Isn't Simple, Even After Approval 3Health News:Getting Social Security Disability Benefits Isn't Simple, Even After Approval 4Health News:Bumrungrad Named Best Small Cap Company in 2008 2Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 2Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 3Health News:Meningitis Angels to Support First Annual World Meningitis Day 2
The Nervous System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the nervous system....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
This handy quick reference is a pragmatic guide to the pathophysiology, diagnosis, and management of cardiovascular disease....
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
Medicine Products: